Publications

5677 Results

S1701, A randomized phase II trial of carboplatin-paclitaxel with and without ramucirumab in patients with locally advanced, recurrent, or metastatic thymic carcinoma

Authors
A Tsao;M Hsieh;M Koczywas;J Tu;J Riess;T Tanvetyanon;B Ma;Y Zhao;M Redman;M Edelman;D Gandara;J Gray;K Kelly
Journal / Conference
JTO Clinical and Research Reports Oct 16;5(12):100738
Year
2024
Research Committee(s)
Lung
PMID
PMID39619274
PMC
PMC11605468
Study Number(s)
S1701

Correlation between tumor size change and outcome in a rare cancer immunotherapy basket trial

Authors
M Othus;S Patel;YK Chae;E Deitrich;H Streicher;E Sharon;R Kurzrock
Journal / Conference
JNCI-Journal of the National Cancer Institute May 8;116(5):673-680
Year
2024
Research Committee(s)
Early Therapeutics and Rare Cancers
PMID
PMID38243705
PMC
PMC11077308
Study Number(s)
S1609

Effect of a weight loss intervention (WLI) on exercise behaviors in women with breast cancer: Results from the Breast Cancer Weight Loss (BWEL) Trial

Authors
J Ligibel;K Ballman;L McCall;P Goodwin;A Weiss;T Crane;M Irwin;C Thomson;O Hahn;P Spears;D Hershman;E Paskett;J Hopkins;V Bernstein;V Stearns;J White;T Wadden;E Winer;L Carey;A Partridge
Journal / Conference
ESMO (September 13-17, 2024, Barcelona, Spain), poster
Year
2024
Research Committee(s)
Breast
Study Number(s)
CTSU/A011401

Beyond Involved-Site Radiotherapy: NRG, COG, ALLIANCE, ECOG, SWOG, and CCTG Consensus Nomenclature for Radiation Targets on NCTN Lymphoma Trials

Authors
O Saifi;C Pinnix;L Ballas;C Kelsey;S Milgrom;S Terezakis;N Figura;R Parikh;J Grecula;J Plastaras;D Hodgson;B Hoppe
Journal / Conference
ASTRO Annual Meeting (September 29 - October 2, 2024, Washington, DC), Quick Pitch Oral Presention; International Journal of Radiation Oncology, Biology, Physics Volume 120:Number 2S
Year
2024
Research Committee(s)
Lymphoma

Evaluation of a prognostic scoring system among patients in the Prospective Comparative Effectiveness Trial for Malignant Bowel Obstruction Study (SWOG 1316)

Authors
C Watson;K Arnold;R Krouse;G Anderson;J Deneve;G Deutsch;B Davidson;A Secord
Journal / Conference
IGCS Meeting (October 16-18, 2024 Dublin, Ire), poster
Year
2024
Research Committee(s)
Palliative Care
Study Number(s)
S1316

Utilization of genomic tumor testing (GTT) among community oncologists participating in SWOG S2108CD

Authors
M Trivedi;A Michel;J Unger;S Colby;L Graham;K Reed;J Fischer;B Symington;S Ramsey;D Hershman;J Rueter
Journal / Conference
ASCO Quality of Care Symposium (September 27-28, 2024, San Francisco, CA), poster;JCO Oncol Pract 20, 2024 (suppl 10; abstr 320)
Year
2024
Research Committee(s)
Cancer Care Delivery
Study Number(s)
S2108CD

The Cost of Doing Business – Drug Costs in Federally-Sponsored Cancer Clinical Trials

Authors
J Unger;H Xiao;R Vaidya;S Threlkel;M Chansky;A Hayes;D Hershman;M LeBlanc
Journal / Conference
ASCO Quality of Care Symposium (September 27-28, 2024, San Francisco, CA), poster; JCO Oncol Pract 20, 2024 (suppl 10; abstr 10)
Year
2024
Research Committee(s)
Cancer Care Delivery

Correlations Between Baseline Tumor Burden and Overall Survival in Patients with Rare Cancers Treated with Immune Checkpoint Inhibitors (NCI/SWOG S1609)

Authors
P Swiecicki;M Othus;S Patel;Y Chae;R Kurzrock
Journal / Conference
SITC (Nov. 6-10, Houston, TX), poster
Year
2024
Research Committee(s)
Early Therapeutics and Rare Cancers
Study Number(s)
S1609

Progression-Free Survival (PFS) with Nivolumab-AVD is superior to Brentuximab Vedotin-AVD with 2-year follow-up of S1826 in Pediatric Advanced Stage (AS) Classic Hodgkin Lymphoma (cHL)

Authors
S Castellino;H Li;A Herrera;A Punnett;M LeBlanc;S Parsons;F Keller;R Drachtman;A Lambert;C Forlenza;A Doan;S Rutherford;A Evens;D Hodgson;R Little;M Smith;H Dillon;J Song;S Smith;J Friedberg;K Kelly
Journal / Conference
ISHL (October 26-28, Cologne, Germany), oral
Year
2024
Research Committee(s)
Lymphoma
Study Number(s)
S1826

Nivolumab-AVD improves 2-year progression-free and overall survival compared to Bv-AVD in older patients (aged =60 years) with advanced stage Hodgkin lymphoma enrolled on SWOG S1826

Authors
S Rutherford;H Li;A Herrera;M LeBlanc;S Ahmed;K Davison;C Casulo;N Bartlett;J Tuscano;B Hess;P Torka;P Kumar;R Jacobs;J Song;B Kahl;J Leonard;S Smith;JW Friedberg;A Evens
Journal / Conference
ISHL (October 26-28, Cologne, Germany), oral
Year
2024
Research Committee(s)
Lymphoma
Study Number(s)
S1826